v3.26.1
Condensed Consolidated Statements of Changes In Stockholders' Equity (Unaudited) - USD ($)
Total
Prefunded Warrants [Member]
Series B Preferred Stock [Member]
Series B Preferred Stock [Member]
Enrollment Warrants [Member]
Common Stock [Member]
Common Stock [Member]
Prefunded Warrants [Member]
Common Stock [Member]
Series B Preferred Stock [Member]
Preferred Stock [Member]
Series A Preferred Stock [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Enrollment Warrants [Member]
Additional Paid-In Capital [Member]
Additional Paid-In Capital [Member]
Prefunded Warrants [Member]
Additional Paid-In Capital [Member]
Series B Preferred Stock [Member]
Additional Paid-In Capital [Member]
Series B Preferred Stock [Member]
Enrollment Warrants [Member]
Treasury Stock [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Balance at Dec. 31, 2024 $ 25,969,576       $ 935     $ 5     $ 155,794,142       $ (5,521,246) $ (124,168,850) $ (135,410)
Balance (in shares) at Dec. 31, 2024         9,343,533     42,019                  
Balance (in shares) at Dec. 31, 2024                             (54,665)    
Stock-based compensation 612,951                   612,951            
Issuance of common stock pursuant to vesting of restricted stock units         $ 1           (1)            
Issuance of common stock pursuant to vesting of restricted stock units (in shares)         2,829                        
Payment of taxes withheld on issuance of restricted stock units (2,072)                   (2,072)            
Net loss (5,196,773)                             (5,196,773)  
Foreign currency translation 24,792                               24,792
Unrealized gain (loss), change in fair value of available-for-sale securities (975)                               (975)
Balance at Mar. 31, 2025 21,407,499       $ 936     $ 5     156,405,020       $ (5,521,246) (129,365,623) (111,593)
Balance (in shares) at Mar. 31, 2025         9,346,362     42,019                  
Balance (in shares) at Mar. 31, 2025                             (54,665)    
Balance at Dec. 31, 2024 25,969,576       $ 935     $ 5     155,794,142       $ (5,521,246) (124,168,850) (135,410)
Balance (in shares) at Dec. 31, 2024         9,343,533     42,019                  
Balance (in shares) at Dec. 31, 2024                             (54,665)    
Conversion of Stock and Warrants into shares (in shares)         2,164,918                        
Balance at Dec. 31, 2025 $ 151,494,375       $ 4,766     $ 3 $ 64   267,719,445       $ (5,521,246) (110,895,167) 186,510
Balance (in shares) at Dec. 31, 2025         47,664,564     28,380 638,558                
Balance (in shares) at Dec. 31, 2025 54,665                           (54,665)    
Stock-based compensation $ 5,459,911                   5,459,911            
Issuance of common stock for exercise of stock options 113,116       $ 4           113,112            
Issuance of common stock for exercise of stock options (in shares)         39,083                        
Issuance of common stock pursuant to vesting of restricted stock units         $ 1           (1)            
Issuance of common stock pursuant to vesting of restricted stock units (in shares)         3,017                        
Payment of taxes withheld on issuance of restricted stock units (4,571)                   (4,571)            
Conversion of Stock and Warrants into shares       $ 2,975,000     $ 677   $ (7) $ 2     $ (670) $ 2,974,998      
Conversion of Stock and Warrants into shares (in shares)     17,000   6,767,900   6,767,900   (67,679) 17,000              
Issuance of common stock and prefunded warrants under the March 2026 Public Offering, net of issuance costs   $ 79,250,629       $ 1,932           $ 79,248,697          
Issuance of common stock and prefunded warrants under the March 2026 Public Offering, net of issuance costs (in shares)           19,324,677                      
Issuance of common stock under the March 2026 Public Offering Underwriters Option, net of issuance costs 7,238,000       $ 200           7,237,800            
Issuance of common stock under the March 2026 Public Offering Underwriters Option, net of issuance costs (in shares)         2,000,000                        
Net loss (18,868,885)                             (18,868,885)  
Foreign currency translation 137,517                               137,517
Unrealized loss, change in fair value of available-for-sale securities, net of reclassification adjustment (546,791)                               (546,791)
Balance at Mar. 31, 2026 $ 227,248,301       $ 7,580     $ 3 $ 59   $ 362,748,721       $ (5,521,246) $ (129,764,052) $ (222,764)
Balance (in shares) at Mar. 31, 2026         75,799,241     28,380 587,879                
Balance (in shares) at Mar. 31, 2026 54,665                           (54,665)